RBC Capital raised the firm’s price target on Oxford Biomedica (OXBDF) to 970 GBp from 930 GBp and keeps an Outperform rating on the shares.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OXBDF:
- Oxford Biomedica Reports Strong Revenue Growth in 2025
- Oxford BioMedica Reports Robust H1 2025 Results, Strengthens Market Position
- Oxford Biomedica Announces Total Voting Rights Update
- Oxford Biomedica price target raised to 930 GBp from 800 GBp at RBC Capital
- Oxford Biomedica Director’s Share Transaction Error and Resolution